Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 5:00 pm Sale | 2025-12-31 | 13G | Roivant Sciences Ltd. ROIV | SB Investment Advisers (UK) Limited | 16,413,603 2.300% | -23,901,524 (-59.29%) | Filing History |
| 2026-02-13 3:32 pm Sale | 2025-12-31 | 13G | Roivant Sciences Ltd. ROIV | Ramaswamy Vivek | 48,428,792 6.800% | -34,527,730 (-41.62%) | Filing History |
| 2026-02-11 11:50 am Purchase | 2025-12-31 | 13G | Roivant Sciences Ltd. ROIV | MORGAN STANLEY MS | 55,491,570 8.000% | 17,844,894 (+47.40%) | Filing History |
| 2026-02-05 1:36 pm Purchase | 2025-12-31 | 13G | Roivant Sciences Ltd. ROIV | FMR LLC | 65,779,464 9.500% | 10,270,183 (+18.50%) | Filing History |
| 2025-12-12 5:20 pm Purchase | 2025-12-12 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 113,327,007 55.900% | 16,666,666 (+17.24%) | Filing History |
| 2025-11-14 4:54 pm Sale | 2025-09-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 23,594,831 3.400% | -10,642,948 (-31.09%) | Filing History |
| 2025-11-14 4:30 pm Sale | 2025-09-30 | 13G | Roivant Sciences Ltd. ROIV | SB Investment Advisers (UK) Limited | 40,315,127 5.800% | -21,742,410 (-35.04%) | Filing History |
| 2025-08-14 5:32 pm Sale | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 34,237,779 5.020% | -11,775,973 (-25.59%) | Filing History |
| 2025-08-14 4:39 pm Sale | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 29,381,635 4.300% | -36,412,144 (-55.34%) | Filing History |
| 2025-08-07 3:04 pm Purchase | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | MORGAN STANLEY MS | 37,646,676 5.500% | 37,646,676 (New Position) | Filing History |
| 2025-08-06 12:11 pm Purchase | 2025-06-30 | 13G | Roivant Sciences Ltd. ROIV | FMR LLC | 55,509,281 8.200% | 6,364,225 (+12.95%) | Filing History |
| 2025-05-15 6:53 pm Purchase | 2025-03-31 | 13G | Roivant Sciences Ltd. ROIV | Ramaswamy Vivek | 82,956,522 11.630% | 1 (+0.00%) | Filing History |
| 2025-05-15 5:29 pm Purchase | 2024-12-31 | 13G | Roivant Sciences Ltd. ROIV | Ramaswamy Vivek | 82,956,521 11.200% | 1,502,000 (+1.84%) | Filing History |
| 2025-05-15 4:35 pm Sale | 2025-03-31 | 13G | Roivant Sciences Ltd. ROIV | VIKING GLOBAL INVESTORS LP | 46,013,752 6.400% | -8,085,314 (-14.95%) | Filing History |
| 2025-04-21 07:54 am Unchanged | 2025-04-21 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 96,660,341 56.900% | 0 (Unchanged) | Filing History |
| 2025-02-25 07:19 am Unchanged | 2025-02-21 | 13D | Arbutus Biopharma Corporation ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 20.500% | 0 (Unchanged) | Filing History |
| 2025-02-18 5:21 pm Unchanged | 2025-02-18 | 13D | Arbutus Biopharma Corporation ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 20.500% | 0 (Unchanged) | Filing History |
| 2025-02-14 2:00 pm Sale | 2024-12-31 | 13G | Roivant Sciences Ltd. ROIV | QVT Financial LP | 65,793,779 9.220% | -926,000 (-1.39%) | Filing History |
| 2025-02-14 09:59 am Sale | 2024-12-31 | 13G | Roivant Sciences Ltd. ROIV | SB Investment Advisers (UK) Limited | 62,057,537 8.500% | -10,974,130 (-15.03%) | Filing History |
| 2025-01-15 4:30 pm Purchase | 2025-01-13 | 13D | Immunovant, Inc. IMVT | Roivant Sciences Ltd. ROIV | 96,660,341 56.900% | 16,845,010 (+21.10%) | Filing History |